SCHRODER INVESTMENT MANAGEMENT GROUP

Position in HIMS — Hims & Hers Health, Inc.

CIK 1086619 London, X0

Back to HIMS Full portfolio

Position in HIMS

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$15,212,221

+$2,039,533 QoQ

Shares Held

732,766

+80.6% QoQ

Ownership

0.317%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in HIMS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $254,809,935 across 13 Drug Manufacturers - Specialty & Generic names. HIMS ranks #5 (6.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	4,376,270	$131,813,250
2	UTHR	UNITED THERAPEUTICS Corp	45,631	$27,058,269
3	ELAN	Elanco Animal Health Inc	1,006,532	$24,086,309
4	HCM	HUTCHMED (China) Ltd	1,477,494	$22,103,310
5	HIMS	Hims & Hers Health, Inc. This page	732,766	$15,212,221
6	NBIX	Neurocrine Biosciences Inc	71,711	$9,447,207
7	SUPN	Supernus Pharmaceuticals, Inc.	176,076	$9,101,368
8	ZTS	Zoetis Inc.	31,553	$3,729,878

All Filings in HIMS

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$15,212,221	732,766	+80.6%	Shares	Sole	2026-05-14
2025-12-31	$13,172,688	405,688	+42.1%	Shares	Sole	2026-02-13
2025-09-30	$16,196,054	285,544	-30.8%	Shares	Sole	2025-11-13
2025-06-30	$20,567,312	412,584	+42.4%	Shares	Sole	2025-08-13
2025-03-31	$8,559,334	289,656	-74.3%	Shares	Sole	2025-05-13
2024-12-31	$27,217,442	1,125,618	-5.2%	Shares	Sole	2025-02-12
2024-09-30	$21,860,560	1,186,784	+228.7%	Shares	Sole	2024-11-13
2024-06-30	$7,289,538	361,047	—	Shares	Sole	2024-08-12
No filing history on record for this holder in this stock.